BioElectronics Corporation (BIEL)

USD 0.0

(0.0%)

Market Cap (In USD)

5.42 Million

Revenue (In USD)

714.7 Thousand

Net Income (In USD)

-722.81 Thousand

Avg. Volume

21.33 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-5.0E-4
PE
-
EPS
-
Beta Value
0.945
ISIN
US09062H1086
CUSIP
09062H108
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Kelly A. Whelan
Employee Count
-
Website
https://www.bielcorp.com
Ipo Date
2004-04-12
Details
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.